{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T23:47:03Z","timestamp":1774828023056,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,29]]},"DOI":"10.7759\/cureus.106082","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T23:21:27Z","timestamp":1774826487000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Coexistence of Anti-CN1A and Anti-NXP2 Myositis-Specific Antibodies in a 63-Year-Old Female From the Philippines With Chronic Progressive Myopathy: A Case Report"],"prefix":"10.7759","author":[{"given":"Pamela Marie M","family":"Cope","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerwin C","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne B","family":"Libiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig F","family":"Damian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Adams and Victor's Principles of Neurology","author":"Ropper AH","year":"2023","unstructured":"Ropper AH, Samuels MA, Klein JP, Prasad S. Adams and Victor's Principles of Neurology. McGraw-Hill Education, Columbus, OH; 2023."},{"key":"ref2","article-title":"Adult inflammatory myopathies: updates on classification and management","volume":"23","author":"Jammal C","year":"2024","unstructured":"Jammal C, Pinal-Fernandez I, Mammen AL. Adult inflammatory myopathies: updates on classification and management. Pract Neurol. 2024, 23:","journal-title":"Pract Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/r625rm","article-title":"Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositis","volume":"40","author":"Salam S","year":"2022","unstructured":"Salam S, Dimachkie MM, Hanna MG, Machado PM. Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositis. Clin Exp Rheumatol. 2022, 40:384-93. 10.55563\/clinexprheumatol\/r625rm","journal-title":"Clin Exp Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.03.012","article-title":"Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: a single centre-experience and literature review: systematic review","volume":"51","author":"Van Horebeek N","year":"2021","unstructured":"Van Horebeek N, Vulsteke JB, Bossuyt X, et al.. Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: a single centre-experience and literature review: systematic review. Semin Arthritis Rheum. 2021, 51:486-94. 10.1016\/j.semarthrit.2021.03.012","journal-title":"Semin Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/mus.28050","article-title":"Positive predictive value of myositis antibody line blot testing in patients with suspected idiopathic inflammatory myopathy","volume":"69","author":"Chang YC","year":"2024","unstructured":"Chang YC, Yang L, Budhram A. Positive predictive value of myositis antibody line blot testing in patients with suspected idiopathic inflammatory myopathy. Muscle Nerve. 2024, 69:626-30. 10.1002\/mus.28050","journal-title":"Muscle Nerve"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.123213","article-title":"Myositis-specific and -associated antibodies in neurological disorders - a retrospective study of 727 patients","volume":"466","author":"Kleiser B","year":"2024","unstructured":"Kleiser B, Hoffmann D, Kowarik MC, Dubois E, Armbruster M, Grimm A, Marquetand J. Myositis-specific and -associated antibodies in neurological disorders - a retrospective study of 727 patients. J Neurol Sci. 2024, 466:123213. 10.1016\/j.jns.2024.123213","journal-title":"J Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.38093","article-title":"Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3","volume":"65","author":"Fiorentino DF","year":"2013","unstructured":"Fiorentino DF, Chung LS, Christopher-Stine L, et al.. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3. Arthritis Rheum. 2013, 65:2954-62. 10.1002\/art.38093","journal-title":"Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23210","article-title":"Cutaneous and systemic findings associated with nuclear matrix protein 2 antibodies in adult dermatomyositis patients","volume":"69","author":"Rogers A","year":"2017","unstructured":"Rogers A, Chung L, Li S, Casciola-Rosen L, Fiorentino DF. Cutaneous and systemic findings associated with nuclear matrix protein 2 antibodies in adult dermatomyositis patients. Arthritis Care Res (Hoboken). 2017, 69:1909-14. 10.1002\/acr.23210","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0186-x","article-title":"Inclusion body myositis: clinical features and pathogenesis","volume":"15","author":"Greenberg SA","year":"2019","unstructured":"Greenberg SA. Inclusion body myositis: clinical features and pathogenesis. Nat Rev Rheumatol. 2019, 15:257-72. 10.1038\/s41584-019-0186-x","journal-title":"Nat Rev Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg IE","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, et al.. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017, 76:1955-64. 10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/448699-a-rare-coexistence-of-anti-cn1a-and-anti-nxp2-myositis-specific-antibodies-in-a-63-year-old-female-from-the-philippines-with-chronic-progressive-myopathy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T23:21:28Z","timestamp":1774826488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/448699-a-rare-coexistence-of-anti-cn1a-and-anti-nxp2-myositis-specific-antibodies-in-a-63-year-old-female-from-the-philippines-with-chronic-progressive-myopathy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.106082","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,29]]}}}